Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerome Ritz

Showing results (231-240 of 315) with videos related to

Pageof 32
Sort By:
Blood|June 2, 2016
Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicityBenjamin L Lampson, Siddha N Kasar, Tiago R Matos, et al.
Blood Advances|May 15, 2024
Active infection at the time of CD34+ selected stem cell boost is associated with treatment failure and poor overall survivalRoman M Shapiro, Haesook T Kim, Remy Dulery, et al.
Cancer Immunology Research|November 7, 2018
Phase I Trial of Autologous CAR T Cells Targeting NKG2D Ligands in Patients with AML/MDS and Multiple MyelomaSusanne H Baumeister, Joana Murad, Lillian Werner, et al.
Blood|April 14, 2016
Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host diseaseJohn Koreth, Haesook T Kim, Kyle T Jones, et al.
Haematologica|January 13, 2018
Bortezomib-based immunosuppression after reduced-intensity conditioning hematopoietic stem cell transplantation: randomized phase II resultsJohn Koreth, Haesook T Kim, Paulina B Lange, et al.
Immunity|July 21, 2016
CD95-Mediated Calcium Signaling Promotes T Helper 17 Trafficking to Inflamed Organs in Lupus-Prone MiceAmanda Poissonnier, Doriane Sanséau, Matthieu Le Gallo, et al.
Cancer Immunology Research|April 11, 2025
First-in-Human Clinical Trial of Vaccination with WDVAX, a Dendritic Cell Activating Scaffold Incorporating Autologous Tumor Cell Lysate, in Metastatic Melanoma PatientsF Stephen Hodi, Anita Giobbie-Hurder, Kwasi Adu-Berchie, et al.
Blood Advances|April 3, 2019
Efficacy and immunologic effects of extracorporeal photopheresis plus interleukin-2 in chronic graft-versus-host diseaseRoger Belizaire, Haesook T Kim, Samuel J Poryanda, et al.
Blood Cancer Discovery|September 5, 2024
Tracking Rare Single Donor and Recipient Immune and Leukemia Cells after Allogeneic Hematopoietic Cell Transplantation Using Mitochondrial DNA MutationsLivius Penter, Nicoletta Cieri, Katie Maurer, et al.
Blood Advances|May 7, 2020
BK virus-specific T-cell immune reconstitution after allogeneic hematopoietic cell transplantationEduardo Espada, Matthew P Cheng, Haesook T Kim, et al.
Pageof 32

Showing results (231-240 of 315) with videos related to

Sort By:
Pageof 32
Blood|June 2, 2016
Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicityBenjamin L Lampson, Siddha N Kasar, Tiago R Matos, et al.
Blood Advances|May 15, 2024
Active infection at the time of CD34+ selected stem cell boost is associated with treatment failure and poor overall survivalRoman M Shapiro, Haesook T Kim, Remy Dulery, et al.
Cancer Immunology Research|November 7, 2018
Phase I Trial of Autologous CAR T Cells Targeting NKG2D Ligands in Patients with AML/MDS and Multiple MyelomaSusanne H Baumeister, Joana Murad, Lillian Werner, et al.
Blood|April 14, 2016
Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host diseaseJohn Koreth, Haesook T Kim, Kyle T Jones, et al.
Haematologica|January 13, 2018
Bortezomib-based immunosuppression after reduced-intensity conditioning hematopoietic stem cell transplantation: randomized phase II resultsJohn Koreth, Haesook T Kim, Paulina B Lange, et al.
Immunity|July 21, 2016
CD95-Mediated Calcium Signaling Promotes T Helper 17 Trafficking to Inflamed Organs in Lupus-Prone MiceAmanda Poissonnier, Doriane Sanséau, Matthieu Le Gallo, et al.
Cancer Immunology Research|April 11, 2025
First-in-Human Clinical Trial of Vaccination with WDVAX, a Dendritic Cell Activating Scaffold Incorporating Autologous Tumor Cell Lysate, in Metastatic Melanoma PatientsF Stephen Hodi, Anita Giobbie-Hurder, Kwasi Adu-Berchie, et al.
Blood Advances|April 3, 2019
Efficacy and immunologic effects of extracorporeal photopheresis plus interleukin-2 in chronic graft-versus-host diseaseRoger Belizaire, Haesook T Kim, Samuel J Poryanda, et al.
Blood Cancer Discovery|September 5, 2024
Tracking Rare Single Donor and Recipient Immune and Leukemia Cells after Allogeneic Hematopoietic Cell Transplantation Using Mitochondrial DNA MutationsLivius Penter, Nicoletta Cieri, Katie Maurer, et al.
Blood Advances|May 7, 2020
BK virus-specific T-cell immune reconstitution after allogeneic hematopoietic cell transplantationEduardo Espada, Matthew P Cheng, Haesook T Kim, et al.
Pageof 32